semaglutide mash approval Novo's Wegovy becomes first GLP-1 drug approved for Semaglutide in MASH with F2-F3
Description
Older adults and patients with baseline sarcopenia risk benefit most
Being overweight can make sleep apnea worse
Never attempt to refreeze a thawed injection, as this significantly increases degradation risk
90K/Mac-2 BP is a new predictive biomarker of response to infliximab therapy in IBD patients
Wen S, Nguyen T, Gong M, et al
